Jump to content

Nipradilol

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Citation bot (talk | contribs) at 18:05, 31 August 2023 (Add: doi-access. | Use this bot. Report bugs. | Suggested by Headbomb | Linked from Wikipedia:WikiProject_Academic_Journals/Journals_cited_by_Wikipedia/Sandbox3 | #UCB_webform_linked 1275/1975). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Nipradilol
Names
IUPAC name
[8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2H-chromen-3-yl] nitrate
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C15H22N2O6/c1-10(2)16-7-12(18)8-21-14-5-3-4-11-6-13(23-17(19)20)9-22-15(11)14/h3-5,10,12-13,16,18H,6-9H2,1-2H3
    Key: OMCPLEZZPVJJIS-UHFFFAOYSA-N
  • CC(C)NCC(COC1=CC=CC2=C1OCC(C2)O[N+](=O)[O-])O
Properties
C15H22N2O6
Molar mass 326.349 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Nipradilol is a beta blocker and nitric oxide donor.[1]

References

[edit]
  1. ^ Inoue, K; Kei Noguchi, K; Masumoto, M; Wakakura, G (2011). "Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma". Clinical Ophthalmology. 5: 1211–6. doi:10.2147/OPTH.S23233. PMC 3180485. PMID 21966188.